Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma
Public ClinicalTrials.gov record NCT02139644. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Low-dose or or Mid-dose Inhaled Corticosteroid Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study was to evaluate the efficacy of fluticasone propionate multidose dry powder inhaler (Fp MDPI) and fluticasone propionate/salmeterol xinafoate multidose dry powder inhaler (FS MDPI) when administered over 12 weeks in patients 12 years of age and older with persistent asthma. Study drug and placebo was supplied in Teva multidose dry powder inhaler (MDPI) devices and provided for participants to use at home. Participants performed spirometry at every visit. Each participant was given a diary at each visit for use until the next visit. Rescue medication (albuterol/salbutamol) was dispensed at each visit, if needed, as determined by the investigational center personnel.
Study identification
- NCT ID
- NCT02139644
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 787 participants
Conditions and interventions
Conditions
Interventions
- FS MDPI Drug
- Fp MDPI Drug
- Placebo MDPI Drug
- albuterol/salbutamol Drug
- Beclomethasone dipropionate Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2014 (Type not available)
- Primary completion
- Sep 2015 (Actual)
- Completion
- Sep 2015 (Actual)
- Last update posted
- Nov 12, 2021
2014 – 2015
United States locations
- U.S. sites
- 76
- U.S. states
- 27
- U.S. cities
- 67
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 12397 | Birmingham | Alabama | — | — |
| Teva Investigational Site 12375 | Glendale | Arizona | — | — |
| Teva Investigational Site 12395 | Cypress | California | — | — |
| Teva Investigational Site 12476 | Encinitas | California | — | — |
| Teva Investigational Site 12586 | Fountain Valley | California | — | — |
| Teva Investigational Site 12591 | Fresno | California | — | — |
| Teva Investigational Site 12372 | Huntington Beach | California | — | — |
| Teva Investigational Site 12365 | Los Angeles | California | — | — |
| Teva Investigational Site 12381 | Los Angeles | California | — | — |
| Teva Investigational Site 12401 | Los Angeles | California | — | — |
| Teva Investigational Site 12394 | Mission Viejo | California | — | — |
| Teva Investigational Site 12490 | Rancho Mirage | California | — | — |
| Teva Investigational Site 12393 | Riverside | California | — | — |
| Teva Investigational Site 12366 | Rolling Hills Estates | California | — | — |
| Teva Investigational Site 12383 | San Diego | California | — | — |
| Teva Investigational Site 12370 | San Jose | California | — | — |
| Teva Investigational Site 12371 | Stockton | California | — | — |
| Teva Investigational Site 12579 | Upland | California | — | — |
| Teva Investigational Site 12379 | Centennial | Colorado | — | — |
| Teva Investigational Site 12386 | Centennial | Colorado | — | — |
| Teva Investigational Site 12596 | Colorado Springs | Colorado | — | — |
| Teva Investigational Site 12584 | Longmont | Colorado | — | — |
| Teva Investigational Site 12484 | Waterbury | Connecticut | — | — |
| Teva Investigational Site 12590 | Waterbury | Connecticut | — | — |
| Teva Investigational Site 12493 | Clearwater | Florida | — | — |
| Teva Investigational Site 12992 | Largo | Florida | — | — |
| Teva Investigational Site 12376 | Miami | Florida | — | — |
| Teva Investigational Site 12390 | Miami | Florida | — | — |
| Teva Investigational Site 12583 | Orlando | Florida | — | — |
| Teva Investigational Site 12481 | Tallahassee | Florida | — | — |
| Teva Investigational Site 12491 | Winter Park | Florida | — | — |
| Teva Investigational Site 12997 | Decatur | Georgia | — | — |
| Teva Investigational Site 12392 | Savannah | Georgia | — | — |
| Teva Investigational Site 12592 | Shiloh | Illinois | — | — |
| Teva Investigational Site 12483 | Lenexa | Kansas | — | — |
| Teva Investigational Site 12399 | Baltimore | Maryland | — | — |
| Teva Investigational Site 12391 | Bethesda | Maryland | — | — |
| Teva Investigational Site 12589 | Columbia | Maryland | — | — |
| Teva Investigational Site 12369 | Rockville | Maryland | — | — |
| Teva Investigational Site 12396 | Fall River | Massachusetts | — | — |
| Teva Investigational Site 12384 | North Dartmouth | Massachusetts | — | — |
| Teva Investigational Site 12585 | North Dartmouth | Massachusetts | — | — |
| Teva Investigational Site 12588 | Ypsilanti | Michigan | — | — |
| Teva Investigational Site 12494 | St Louis | Missouri | — | — |
| Teva Investigational Site 12595 | St Louis | Missouri | — | — |
| Teva Investigational Site 12594 | Missoula | Montana | — | — |
| Teva Investigational Site 12385 | Ocean City | New Jersey | — | — |
| Teva Investigational Site 12380 | Skillman | New Jersey | — | — |
| Teva Investigational Site 12587 | Brooklyn | New York | — | — |
| Teva Investigational Site 12485 | Rockville Centre | New York | — | — |
| Teva Investigational Site 12475 | Huntersville | North Carolina | — | — |
| Teva Investigational Site 12364 | Raleigh | North Carolina | — | — |
| Teva Investigational Site 12374 | Canton | Ohio | — | — |
| Teva Investigational Site 12480 | Cincinnati | Ohio | — | — |
| Teva Investigational Site 12492 | Cincinnati | Ohio | — | — |
| Teva Investigational Site 12487 | Middleburg Heights | Ohio | — | — |
| Teva Investigational Site 12488 | Sylvania | Ohio | — | — |
| Teva Investigational Site 12377 | Edmond | Oklahoma | — | — |
| Teva Investigational Site 12368 | Medford | Oregon | — | — |
| Teva Investigational Site 12382 | Portland | Oregon | — | — |
| Teva Investigational Site 12400 | Pittsburgh | Pennsylvania | — | — |
| Teva Investigational Site 12473 | Upland | Pennsylvania | — | — |
| Teva Investigational Site 12389 | Greenville | South Carolina | — | — |
| Teva Investigational Site 12580 | Mt. Pleasant | South Carolina | — | — |
| Teva Investigational Site 12398 | Orangeburg | South Carolina | — | — |
| Teva Investigational Site 12991 | Knoxville | Tennessee | — | — |
| Teva Investigational Site 12990 | Cypress | Texas | — | — |
| Teva Investigational Site 12373 | Dallas | Texas | — | — |
| Teva Investigational Site 12402 | El Paso | Texas | — | — |
| Teva Investigational Site 12582 | New Braunfels | Texas | — | — |
| Teva Investigational Site 12363 | San Antonio | Texas | — | — |
| Teva Investigational Site 12482 | San Antonio | Texas | — | — |
| Teva Investigational Site 12477 | Waco | Texas | — | — |
| Teva Investigational Site 12478 | Murray | Utah | — | — |
| Teva Investigational Site 12388 | South Burlington | Vermont | — | — |
| Teva Investigational Site 12378 | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02139644, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 12, 2021 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02139644 live on ClinicalTrials.gov.